MYH9 and neoplasm: Liu et al. also observed that CB stimulates MAP2K4, subsequently inhibiting the MYH9/GSK3β/β-catenin pathway and downstream tumor stem cell and EMT signaling, resulting in a significant reversal of EBV-Mir-BarT2-induced cisplatin resistance in nasopharyngeal carcinoma (Liu Y. et al., 2019).